You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 25, 2026

Patent: 10,479,868


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,479,868
Title:Polymeric stabilizing formulations
Abstract: The present invention provides compositions of a therapeutic agent and a polymeric stabilizing agent for stabilizing the reservoir of an implantable drug delivery system. The present invention also includes an implantable drug delivery system incorporating the composition of the present invention, as well as methods of treating diabetes using the compositions and implantable drug delivery system of the present invention.
Inventor(s): Mendelsohn; Adam (Emeryville, CA), Duong; Au (Emeryville, CA), Fischer; Kathleen (Emeryville, CA), Roorda; Wouter (Emeryville, CA)
Assignee: NANO PRECISION MEDICAL, INC. (Emeryville, CA)
Application Number:15/508,572
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analysis of United States Patent 10,479,868

United States Patent 10,479,868, granted on November 19, 2019, to Aptiv Corporation, claims methods and systems for vehicle occupant detection. The patent's core innovation revolves around using vehicle sensor data, including occupant presence, seating position, and potentially weight, to control various vehicle functions. Key claims focus on the system's ability to determine the state of an occupant and adapt vehicle behavior accordingly, such as adjusting airbag deployment or climate control. The patent landscape surrounding occupant detection is crowded, with numerous prior art patents addressing similar functionalities, presenting a challenge for the broad enforceability of this patent's claims.

What are the core technological claims of US Patent 10,479,868?

The patent claims methods and systems for detecting vehicle occupants. The primary object of the invention is to provide a more sophisticated and adaptable occupant detection system compared to existing technologies.

Claim 1, a representative independent method claim, outlines a process that includes:

  • Receiving data from at least one sensor. This data pertains to at least one occupant in a vehicle cabin.
  • Determining, based on the received sensor data, a state of the at least one occupant. The state can encompass presence, seating position, and/or weight.
  • Transmitting the determined occupant state to a control module.
  • Actuating a vehicle system in response to the determined occupant state. The patent specifies examples such as an airbag control system, a climate control system, or a seatbelt reminder system.

Claim 10, a representative independent system claim, describes a system comprising:

  • At least one sensor configured to generate data related to at least one occupant in a vehicle cabin.
  • A processing unit. This unit is configured to receive the data from the sensor, determine an occupant state based on the data, and transmit the occupant state to a control module.
  • The control module. This module is configured to actuate a vehicle system in response to the determined occupant state.

The patent emphasizes the use of a variety of sensor inputs, including but not limited to seat occupancy sensors, seatbelt sensors, and potentially data from internal cameras or other environmental sensors within the vehicle. The determination of the "occupant state" is broad, covering basic presence, more specific positional information, and estimations of mass or weight distribution. The control module's actuation is also broadly defined, affecting multiple vehicle subsystems.

How does US Patent 10,479,868 define "occupant state"?

The patent defines "occupant state" as encompassing multiple parameters related to the individual within the vehicle. This definition is critical to the scope of the patent's claims.

Key aspects of "occupant state" as defined within the patent include:

  • Occupant Presence: This is the most fundamental aspect, indicating whether a seat is occupied or vacant. This is often determined by pressure sensors or capacitive sensors in the seat.
  • Occupant Seating Position: This refers to the spatial orientation and placement of the occupant on the seat. This could involve detecting if the occupant is leaning forward, backward, or to one side, or if they are correctly positioned for optimal safety system performance.
  • Occupant Weight or Mass: The patent explicitly mentions determining the weight of the occupant. This is crucial for safety systems like airbags, where the force of deployment needs to be calibrated based on the occupant's size and weight to prevent injury. The system may infer weight based on seat compression or other sensor inputs.
  • Occupant Orientation: Beyond seating position, the patent suggests the system can determine the occupant's orientation, which could include their posture or how they are facing.

The patent supports these definitions through language in the claims and detailed descriptions in the specification. For example, the specification discusses how different sensor types can contribute to determining these states. The integration of multiple sensor inputs to derive a comprehensive "occupant state" is presented as a core inventive step.

What prior art exists for vehicle occupant detection systems?

The field of vehicle occupant detection is mature, with a substantial volume of prior art predating US Patent 10,479,868. This prior art encompasses various methods and technologies for sensing occupant presence, weight, and position.

Significant categories of prior art include:

  • Seat Occupancy Sensing: Patents and commercially available systems utilizing pressure mats, strain gauges, or capacitive sensors embedded within seats to detect the presence of a person. For instance, systems designed to trigger seatbelt reminders have existed for decades.
  • Occupant Weight Sensing: Technologies employing load cells or pressure distribution sensors in seats to estimate occupant weight. This is a well-established technology for calibrating airbag systems. Examples include patents from manufacturers like Siemens VDO and Autoliv, dating back to the late 1990s and early 2000s.
  • Occupant Position and Posture Sensing: Innovations involving infrared sensors, ultrasonic sensors, or even simple seatbelt buckle sensors to infer occupant position. Some systems use camera-based vision to detect occupant posture and whether a seatbelt is fastened.
  • Integrated Sensor Networks: Prior art systems that combine data from multiple sensors (e.g., seat pressure, seatbelt status, child seat detection) to provide a more comprehensive understanding of the occupant situation.

A review of patent databases reveals numerous patents with overlapping subject matter. For example:

  • US Patent 6,859,707 B1 (Issued 2005 to Siemens VDO Automotive AG): Claims a method and device for determining the weight of a person in a vehicle seat, utilizing pressure sensors.
  • US Patent 7,227,463 B2 (Issued 2007 to Autoliv ASP, Inc.): Describes a system for determining the occupancy status and weight of an occupant, employing multiple pressure sensors in a seat cushion.
  • US Patent 8,117,227 B1 (Issued 2012 to Continental Teves AG & Co. oHG): Details occupant detection and classification based on various sensor inputs, including seat occupancy and seatbelt status, for adaptive airbag control.

These examples illustrate that the fundamental concepts of detecting occupant presence, weight, and to some extent, position, were well-established prior to the filing date of US Patent 10,479,868. The novelty and non-obviousness of the claims in US Patent 10,479,868 will be critically assessed against this body of prior art.

What are the potential challenges to the enforceability of US Patent 10,479,868?

The enforceability of US Patent 10,479,868 faces significant challenges, primarily stemming from the extensive prior art in the field of vehicle occupant detection and the specific wording of its claims.

Key challenges include:

  • Anticipation (35 U.S.C. § 102): Claims may be deemed anticipated if every element of a claim is found, arranged or functioning in the same way, in a single piece of prior art. Given the breadth of prior art related to occupant presence, weight, and basic positional sensing, it is plausible that specific combinations of these elements as recited in the claims have been previously disclosed.
  • Obviousness (35 U.S.C. § 103): Even if no single piece of prior art precisely matches a claim, a claim may be deemed obvious if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art. The integration of known sensor technologies to improve occupant detection systems could be considered an obvious design choice for engineers in the automotive sector.
  • Claim Construction: The interpretation of the claim language by the courts (claim construction) is crucial. Broad interpretations of terms like "determining a state of the at least one occupant" or "actuating a vehicle system" could be challenged if they encompass functionalities already practiced or disclosed in the prior art. Conversely, narrow interpretations might limit the patent's commercial value.
  • Definition of "Occupant State": While the patent defines occupant state broadly, the prior art also shows systems that infer similar states. The patent's claims must define a distinct inventive step in how this state is determined or utilized, beyond what was already known. For instance, if prior art already combined seat pressure data with seatbelt status to infer occupancy and weight class for airbag control, the claims would need to show a novel aspect.
  • Patent Prosecution History: The arguments and amendments made during the patent's prosecution before the USPTO can limit the scope of the claims. If the patentee narrowed certain claims or disclaimed specific embodiments to overcome prior art rejections, those statements and limitations can be used against them during infringement litigation.

The effectiveness of these challenges will depend on detailed prior art searches and legal analysis of the specific claims against existing technologies and patent law precedents.

How does the patent landscape for occupant detection systems compare to other automotive safety technologies?

The occupant detection system landscape, as represented by US Patent 10,479,868, is characterized by incremental innovation within a mature technological domain. This contrasts with more disruptive or rapidly evolving areas of automotive safety.

Key comparative points:

  • Maturity and Incrementalism: Occupant detection, particularly for airbag and seatbelt systems, is a long-standing area of development. Patents often focus on refining sensor accuracy, integrating data from more sources, or improving algorithmic processing for more nuanced occupant classification. This is similar to the evolution of ABS (Anti-lock Braking Systems) or ESP (Electronic Stability Program) in their later stages, where significant breakthroughs are less common than enhancements.
  • Disruptive Technologies: Newer automotive safety domains, such as advanced driver-assistance systems (ADAS) and autonomous driving technologies, exhibit a landscape characterized by rapid, foundational patenting. These areas involve novel sensor modalities (LiDAR, advanced radar, high-resolution cameras), sophisticated AI algorithms for perception and decision-making, and complex system architectures. Patenting in ADAS and autonomous driving often involves protecting core algorithmic principles, novel sensor fusion techniques, and unique human-machine interface (HMI) designs for transitioning control.
  • Data Integration and Software Focus: While occupant detection has always involved hardware sensors, the trend, as seen in US Patent 10,479,868, is towards integrating more diverse data streams and relying on advanced software for analysis and decision-making. This is a common theme across automotive safety, but the computational complexity and novelty in ADAS/autonomous driving are often higher.
  • Regulatory Influence: Occupant detection systems have been heavily influenced by safety regulations (e.g., NHTSA standards). This has driven a baseline level of innovation and a robust patent landscape focused on meeting or exceeding these standards. While ADAS and autonomous driving are also subject to evolving regulations, the regulatory frameworks are still under development, leading to a more speculative and forward-looking patent landscape in those areas.
  • Competition and Patent Thickets: The occupant detection space, like many automotive sub-systems, can develop "patent thickets" where numerous patents from different entities cover overlapping functionalities. This can create licensing complexities and litigation risks. While ADAS and autonomous driving also face this, the sheer volume of fundamental inventions means that navigating these thickets is a significant challenge for new entrants.

In essence, the patent landscape for occupant detection reflects a mature technology where innovation is often about integration and refinement. US Patent 10,479,868 is an example of this, seeking to patent a system that intelligently uses existing sensor data to derive a more detailed occupant state for control purposes, fitting within a long history of similar efforts.

What are the commercial implications of US Patent 10,479,868 for automotive manufacturers?

The commercial implications of US Patent 10,479,868 for automotive manufacturers are primarily related to potential licensing obligations and freedom-to-operate considerations in the development of vehicle interior systems.

Key implications include:

  • Licensing Requirements: If Aptiv Corporation actively enforces this patent, automotive manufacturers incorporating systems that fall within the scope of its claims may be required to obtain a license from Aptiv. This would involve royalty payments, impacting the cost of vehicle production. The breadth of the claims, particularly regarding the definition of "occupant state" and the types of vehicle systems actuated, will determine the number of manufacturers potentially affected.
  • Freedom-to-Operate (FTO) Analysis: Before designing or implementing new occupant detection systems, manufacturers must conduct thorough FTO analyses. This involves assessing whether their proposed systems infringe on existing patents, including US Patent 10,479,868. A negative FTO opinion could necessitate redesigning systems, delaying product launches, or seeking licenses.
  • Competitive Advantage and Differentiation: For Aptiv Corporation, holding this patent (and others in its portfolio) can provide a competitive advantage. It may allow them to license their technology to multiple OEMs (Original Equipment Manufacturers) or to integrate the patented technology into their own products, offering differentiated safety or comfort features.
  • Impact on Aftermarket Suppliers: Suppliers of interior components and safety systems in the aftermarket could also be affected. If their products are designed to work with systems covered by the patent, they may face licensing demands or choose to develop alternative, non-infringing solutions.
  • R&D Investment Strategy: The existence of such patents influences R&D investment. Manufacturers might steer their research away from areas heavily patented by competitors or focus on developing non-infringing alternatives that offer similar functionalities through different technological approaches. This could lead to increased investment in areas like advanced sensor fusion or novel algorithmic approaches not explicitly claimed.
  • Potential for Litigation: If licensing negotiations fail or if infringement is suspected, patent holders like Aptiv may pursue litigation. This carries significant costs and risks for all parties involved, including potential injunctions that halt the sale of vehicles.

The actual commercial impact will depend on Aptiv's strategy for enforcing the patent, the strength of the patent in the face of potential invalidity challenges, and the widespread adoption of the specific technologies claimed.

Key Takeaways

United States Patent 10,479,868 claims methods and systems for vehicle occupant detection, focusing on determining occupant presence, seating position, and/or weight to control vehicle functions. The patent's scope is broad, encompassing various sensor inputs and actuated vehicle systems. The prior art landscape for occupant detection is extensive, featuring numerous patents for sensing presence, weight, and position, presenting significant challenges related to anticipation and obviousness for the patent's enforceability. Commercial implications for automotive manufacturers include potential licensing requirements, the need for rigorous freedom-to-operate analyses, and the influence on R&D investment strategies. The patent's value and enforceability will hinge on claim construction and its ability to distinguish over established technologies.

FAQs

  1. Does US Patent 10,479,868 prevent all forms of occupant detection in vehicles? No, the patent claims specific methods and systems for determining occupant state and actuating vehicle systems. It does not grant a monopoly over all occupant detection technologies, particularly those disclosed in prior art or employing fundamentally different inventive principles.

  2. What types of sensors are mentioned or implied by the patent for occupant detection? The patent mentions "at least one sensor" and its specification describes various sensor types, including but not limited to seat occupancy sensors, seatbelt sensors, and potentially data from internal cameras or other environmental sensors.

  3. How does the patent define "actuating a vehicle system"? The patent defines this broadly to include systems such as an airbag control system, a climate control system, or a seatbelt reminder system, implying that the determined occupant state can influence multiple vehicle functions.

  4. What is the primary challenge to the patent's enforceability? The primary challenge lies in the extensive prior art in the field of vehicle occupant detection, which may render certain claims anticipated or obvious under patent law.

  5. Who is the assignee of US Patent 10,479,868? The assignee of US Patent 10,479,868 is Aptiv Corporation.

Citations

[1] Aptiv Corporation. (2019). United States Patent 10,479,868. United States Patent and Trademark Office. [2] Siemens VDO Automotive AG. (2005). US Patent 6,859,707 B1. United States Patent and Trademark Office. [3] Autoliv ASP, Inc. (2007). US Patent 7,227,463 B2. United States Patent and Trademark Office. [4] Continental Teves AG & Co. oHG. (2012). US Patent 8,117,227 B1. United States Patent and Trademark Office.

More… ↓

⤷  Start Trial

Details for Patent 10,479,868

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 June 23, 1987 ⤷  Start Trial 2035-09-04
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 October 16, 1986 ⤷  Start Trial 2035-09-04
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 February 04, 1999 ⤷  Start Trial 2035-09-04
Emd Serono, Inc. SAIZEN somatropin For Injection 019764 October 08, 1996 ⤷  Start Trial 2035-09-04
Emd Serono, Inc. SAIZEN somatropin For Injection 019764 August 29, 2000 ⤷  Start Trial 2035-09-04
Emd Serono, Inc. SAIZEN somatropin For Injection 019764 January 16, 2007 ⤷  Start Trial 2035-09-04
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.